CODX: Co-Diagnostics, Inc. Common Stock Company Profile & Statistics

About

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.

Info & Links

CEO

Dwight Egan

Headquarters

2401 S. FOOTHILL DRIVE, SUITE D
SALT LAKE CITY, UT 84109, UNITED STATES

Auditor

Haynie & Company

Share holders

154

Employees

155

Co-Diagnostics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

11.01M

Enterprise Value

213.36K

Enterprise Value/EBITDA(ttm)

-0.01

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.09

Price to Book(mrq)

0.35

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

31.17%

Operating Margin(ttm)

-563.90%

Profit Margin(ttm)

-2794.04%

Return on Equity(ttm)

-54.94%

Return on Invested Capital(ttm)

-57.89%

Return on Assets(ttm)

-49.28%

Income Statement

Revenue(ttm)

7.32M

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

3.61M

EBITDA(ttm)³

-38.67M

Net Income Available to Common(ttm)

-41.28M

Diluted EPS(ttm)

-1.38

Share Statistics

Beta (5Y Monthly)

-0.63

52-Week Change

-70.09%

S&P 500 52-Week Change

3.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

31.93M

Dividend Yield

0.00%

Float⁴

29.98M

% Held by Insiders

6.10%

% Held by Institutions

14.99%

Balance Sheet

Total Cash(mrq)

37.66M

Total Cash Per Share(mrq)

1.18

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.41%

Quick Ratio(mrq)

6.70%

Book Value Per Share(mrq)

1.64

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.96

Free Cash Flow(ytd)

-29.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CODX

Co-Diagnostics, Inc. Common Stock

Co-Diagnostics, Inc. Common Stock Profile